2 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 3 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Active not recruiting 1 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow carfentanil: new trials by email Literature Review of carfentanil trials Research Report on carfentanil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opioidergic and Noradrenergic Systems in Central Parkisonian Pain PET-MRI exam with administration of [11C]Carfentanil, PET-MRI exam with administration of [11C]Yohimbine - Parkinson Disease | Not applicable | Not yet recruiting | Hospices Civils de Lyon | 55 | 2025-10-01 | 2025-08-17 |
| Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing CVL-354, [11C]-LY2795050, [11C]-carfentanil - Opioid Use Disorder | Phase 1 | Completed | Cerevel Therapeutics, LLC | 19 | 2023-03-02 | 2025-07-14 |
| Multi-System Analysis of Opioid Receptor Binding Carfentanil, C-11, Naloxone, Loperamide Hydrochloride - Healthy, Opioid Use Disorder | Phase 1 | Active not recruiting | University of Pennsylvania | 25 | 2022-09-20 | 2026-03-30 |
| Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain Deep brain stimulation, Cervel Neurotech, Multi-coil TMS, 11C-Carfentanil - Neuralgia | Phase 2 | Terminated | University of Aarhus | 3 | 2014-04-01 | 2021-09-14 |
| Effects of Smoking on Opioid Receptor Binding: A PET Study Nicotine, Carfentanil - Substance-related Discorder | Phase 1 | Completed | National Institute on Drug Abuse (NIDA) | 26 | 2008-01-17 | 2018-04-05 |
Opioid-Related Disorders (2) · Neuralgia (1) · Pain (1) · Parkinson Disease (1) · Smoking (1)
Cerevel Therapeutics, LLC (1) · Hospices Civils de Lyon (1) · National Institute on Drug Abuse (NIDA) (1) · University of Aarhus (1) · University of Pennsylvania (1)
United States (3) · Denmark (1) · France (1)
4UH3DA052166-02 (1)